Lower TZAP expression was associated with a poor prognosis in lung adenocarcinomas (OS and DFS), pancreatic adenocarcinomas (OS and DFS), cervical squamous cell carcinomas (OS), endocervical adenocarcinomas (OS), kidney renal papillary cell carcinomas (OS), and kidney renal clear cell carcinomas (DFS), according to TCGA data. This evidence concerns the gene ZBTB48 and endocervical adenocarcinoma.